How do Pfizer and AstraZeneca vaccines fare against the variant found in India?
1/5
Protection and efficacy
According to a study conducted by the Pasteur Institute in France, the vaccine developed by Pfizer is slightly less effective but still is able to offer protection against the coronavirus variant found in India.
2/5
Pfizer
The study was conducted on 28 healthcare workers, 16 of whom were given both the doses of the Pfizer vaccine, while 12 received one dose of the AstraZeneca vaccine. The results showed that those who received the Pfizer doses saw a reduction in their antibodies against the variant from India, but were still protected.
3/5
AstraZeneca
With AstraZeneca, those who received the dose showed lesser antibodies neutralising the variant. The Pfizer dose also provided 3-6 times lesser antibodies against the UK variant to those who have already been infected.
Amazon Top Deals
POWERED BY
Crompton Ozone 75 Litres Desert Air Cooler for home | Large & Easy Clean Ice Chamber | 4-Way Air Deflection | High Density Honeycomb Pads | Everlast Pump | Auto Fill| 3 Year Brand Warranty
₹9,798Buy Now43%
OFF
atomberg Studio Smart+ 1200mm BLDC Ceiling Fan with IoT & Remote | BEE 5 star Rated Energy Efficient Ceiling Fan | High Air Delivery with LED Indicators | 3 Year Warranty (Earth Brown)
₹5,882Buy Now36%
OFF
LG 32 L Convection Microwave Oven (MC3286BRUM, Black, 360° Motorised Rotisserie for Bar-be-queing, 301 Auto Cook Menu, Stainless steel cavity, Indian Cuisine, Tandoor Se, Steam Clean & Diet Fry)
₹19,340Buy Now19%
OFF
4/5
Resisting antibodies
The study has shown that the variant has developed partial resistance to antibodies, which spell bad news for the world. Since the pandemic began, many varients have been found in different countries.
5/5
Closing borders
Against all the previous mutations, it is the one in India that is especially dangerous and has been recorded in 53 territories, leading to many European countries imposing tighter restrictions on those arriving from these countries.